Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-1 Concentration Comparison by Assay Type

Radioligand Binding (IC50 Determination) 0.1 nM – 10 µM (10-point curve) 100–200 µL per well All MC receptors (non-selective) Use concentrations spanning 3 logs above and below expected IC50. For MC1R this means starting at 0.1 nM cAMP Functional Assay (EC50)

This comparison does not assign a generated winner or score.

  • Radioligand Binding (IC50 Determination)
  • 0.1 nM – 10 µM (10-point curve)
  • 100–200 µL per well
  • All MC receptors (non-selective)
  • Use concentrations spanning 3 logs above and below expected IC50. For MC1R this means starting at 0.1 nM
  • cAMP Functional Assay (EC50)
  • 0.1 nM – 100 nM (8-point curve)
  • 50–100 µL per well
  • MC1R, MC3R, MC4R (subtype-dependent)
  • Keep maximum concentration below 1 µM to preserve receptor subtype specificity in mixed-receptor cell lines
  • Melanogenesis Assay (Melanocyte Culture)
  • 10 nM – 1 µM (single-dose or dose-response)
  • 500 µL – 2 mL per well (6–24 well format)
  • MC1R (primary)
  • Maximal melanin synthesis typically observed at 100 nM. Higher concentrations produce no additional effect
  • Murine In Vivo (Subcutaneous Injection)
  • 1–5 mg/mL stock; dose 0.5–2 mg/kg
  • 5–50 µL per injection (25 g mouse)
  • Systemic (all MC receptors)
  • Prepare fresh stock weekly. Peptide degradation in reconstituted solution reduces effective dose by 10–15% after 7 days at 4°C
  • Non-Human Primate Dermatology
  • 2–10 mg/mL stock; dose 0.1–0.5 mg/kg
  • 100–500 µL per injection
  • MC1R (dermal melanocytes)
  • Higher concentrations allow smaller injection volumes but require aggregation testing via light scattering before use
More references

Related material